Allocating HIV prevention funds in the United States: Recommendations from an optimization model

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Lasry, Arielle ^a   Sansom, Stephanie L ^a   Hicks, Katherine A ^b   Uzunangelov, Vladislav ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG ABUSE; FINANCIAL MANAGEMENT; HEALTH CARE PLANNING; HEALTH STATUS; HIGH RISK POPULATION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE HOMOSEXUAL; MEDICAL DECISION MAKING; PARENT COUNSELING; PATIENT EDUCATION; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; RESOURCE ALLOCATION; REVIEW; STATISTICAL MODEL; UNITED STATES; VIRUS TRANSMISSION; ARTICLE; DRUG USE; ECONOMICS; HOMOSEXUALITY; HUMAN; INCIDENCE; LEGAL ASPECT; MALE; PUBLIC HEALTH SERVICE;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DRUG USERS; HEALTH PRIORITIES; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MODELS, ECONOMIC; PREVENTIVE HEALTH SERVICES; UNITED STATES;

EID: 84862001093     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037545     Document Type: Review

References (43)

1. Hall HI, Song R, Rhodes P, Prejean J, An Q, et al. (2008) Estimation of HIV Incidence in the United States. Journal of the American Medical Association 300: 520-529.
2. Prejean J, Song R, Hernandez A, Ziebell R, Green T, et al. (2011) Estimated HIV Incidence in the United States, 2006-2009. PLoS ONE 6: e17502.
3. Campsmith ML, Rhodes PH, Hall HI, Green TA, (2010) Undiagnosed HIV Prevalence Among Adults and Adolescents in the United States at the End of 2006. Journal of Acquired Immune Deficiency Syndromes 53: 619-624.
4. Centers for Disease Control and Prevention (2010) Prevalence and awareness of HIV infection among men who have sex with men - 21 cities, United States, 2008. Morbidity and Mortality Weekly Report 59: 1201-1207.
5. NASTAD and the Kaiser Family Foundation (2009) The national HIV prevention inventory: the state of HIV prevention across the U.S.
6. Siegfried N, Muller M, Deeks JJ, Volmink J, (2009) Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database of Systematic Reviews 2: CD003362.
7. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, et al. (2010) Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 363: 2587-2599.
8. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 Infection with Early Antiretroviral Therapy. New England Journal of Medicine 365: 493-505.
9. Lasry A, Sansom S, Hicks K, Uzunangelov V, (2011) A model for allocating CDC's HIV prevention resources in the United States. Health Care Manag Science 14: 115-124.
10. Marks G, Crepaz N, Senterfitt J, Janssen RS, (2005) Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes 39: 446-453.
11. Weinhardt LS, Carey MP, Johnson BT, Bickham NL, (1999) Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. American Journal of Public Health 89: 1397-1405.
12. Marks G, Millett G, Bingham T, Bond L, Lauby J, et al. (2009) Understanding differences in HIV sexual transmission among Latino and black men who have sex with men: The Brothers y Hermanos study. AIDS and Behavior 13: 682-690.
13. Marks G, Crepaz N, Janssen RS, (2006) Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 20: 1447-1450.
14. Capasso V, Serio G, (1978) A generalization of the Kermack-McKendrick deterministic epidemic model. Mathematical Biosciences 42: 43-61.
15. Centers for Disease Control and Prevention (2008) HIV Surveillance Report, 2006. Vol 18. Atlanta, GA.
16. Hall HI, Song R, Gerstle JE 3rd, Lee LM, (2006) Assessing the completeness of reporting of human immunodeficiency virus diagnoses in 2002-2003: capture-recapture methods. Am J Epidemiol 164: 391-397.
17. Anderson J, Mosher W, Chandra A, (2006) Measuring HIV risk in the U.S. population aged 15-44: results from Cycle 6 of the National Survey of Family Growth. Advance Data 23: 1-27.
18. Brady J, Friedman S, Cooper HLF, Flom P, Tempalski B, et al. (2008) Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. Journal of urban health 85: 323-351.
19. Cooper HL, Friedman SR, Brady J, Tempalski B, Gostnell K, (2007) Temporal trends in injection drug use among Black and White adult residents of US metropolitan areas (1992-2002). 2007 Annual meeting of the American Public Health Association. Washington, DC.
20. Centers for Disease Control and Prevention (Database accessed May 2008) HIV Counseling and Testing System (CTS) 2002-2005.
21. Farnham PG, Hutchinson AB, Sansom SL, Branson BM, (2008) Comparing the costs of HIV screening strategies and technologies in health-care settings. Public Health Rep 123 (Suppl 3): 51-62.
22. Shrestha RK, Clark HA, Sansom SL, Song B, Buckendahl H, et al. (2008) Cost-effectiveness of finding new HIV diagnoses using rapid HIV testing in community-based organizations. Public Health Rep 123 (Suppl 3): 94-100.
23. Rotheram-Borus MJ, Swendeman D, Comulada WS, Weiss RE, Lee M, et al. (2004) Prevention for substance-using HIV-positive young people: telephone and in-person delivery. J Acquir Immune Defic Syndr 37 (Suppl 2): S68-77.
24. Kalichman SC, Rompa D, Cage M, DiFonzo K, Simpson D, et al. (2001) Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. Am J Prev Med 21: 84-92.
25. Healthy Living Project Team (2007) Effects of a behavioral intervention to reduce risk of transmission among people living with HIV: the healthy living project randomized controlled study. J Acquir Immune Defic Syndr 44: 213-221.
26. Fisher JD, Fisher WA, Cornman DH, Amico RK, Bryan A, et al. (2006) Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J Acquir Immune Defic Syndr 41: 44-52.
27. Wingood GM, DiClemente RJ, Mikhail I, Lang DL, McCree DH, et al. (2004) A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program. Journal of Acquired Immune Deficiency Syndromes 37: S58-S67.
28. Jemmott LS, Jemmott JB, 3rd, O'Leary A, (2007) Effects on sexual risk behavior and STD rate of brief HIV/STD prevention interventions for African American women in primary care settings. Am J Public Health 97: 1034-1040.
29. Scholes D, McBride CM, Grothaus L, Civic D, Ichikawa LE, et al. (2003) A tailored minimal self-help intervention to promote condom use in young women: results from a randomized trial. AIDS 17: 1547-1556.
30. Crosby R, DiClemente RJ, Charnigo R, Snow G, Troutman A, (2009) A brief, clinic-based, safer sex intervention for heterosexual African American men newly diagnosed with an STD: A randomized controlled trial. American journal of public health 99: S96-S103.
31. National Compensation Survey. Bureau of Labor Statistics (June 2006 (Published in June 2007)).
32. Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, et al. (2006) The lifetime cost of current human immunodeficiency virus care in the United States. Medical Care 44: 990-997.
33. Yorke JA, Hethcote HW, Nold A, (1978) Dynamics and control of the transmission of gonorrhea. Sex Transm Dis 5: 51-56.
34. Brandeau ML, Zaric GS, (2009) Optimal investment in HIV prevention programs: more is not always better. Health Care Manag Sci 12: 27-37.
35. Guinness L, Kumaranayake L, Hanson K, (2007) A cost function for HIV prevention services: is there a 'u'- shape? Cost Effectiveness and Resource Allocation 5: 13.
36. Silva A, Glick NR, Lyss SB, Hutchinson AB, Gift TL, et al. (2007) Implementing an HIV and sexually transmitted disease screening program in an emergency department. Ann Emerg Med 49: 564-572.
37. Chesson HW, Greenberg JB, Hennessy M, (2002) The cost-effectiveness of the WINGS intervention: a program to prevent HIV and sexually transmitted diseases among high-risk urban women. BMC Infect Dis 2: 24.
38. Sweat M, O'Donnell C, O'Donnell L, (2001) Cost-effectiveness of a brief video-based HIV intervention for African American and Latino sexually transmitted disease clinic clients. AIDS 15: 781-787.
39. Shrestha RK, Sansom SL, Farnham PG, (2012) Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions. J Public Health Manag Pract 18: 259-267.
40. Lasry A, Richter A, Lutscher F, (2009) Recommendations for increasing the use of HIV/AIDS resource allocation models. BMC Public Health 9: S8.
41. Hutchinson AB, Farnham PG, Duffy N, Wolitski RJ, Sansom SL, et al. (2012) Return on Public Health Investment: CDC's Expanded HIV Testing Initiative. Journal of Acquired Immune Deficiency Syndromes 59: 281-286.
42. The White House Office of National AIDS Policy (July 2010) National HIV/AIDS Strategy for the United States. Washington, DC.
43. Centers for Disease Control and Prevention (2008) Subpopulation Estimates from the HIV Incidence Surveillance System - United States, 2006. Morbidity and Mortality Weekly Report 57: 985-989.